Dryfiber, LLC

DRYFIBER is commercializing Cornell’s fluorine-free, durable water and oil repellent (DWOR).  Once applied in a standard manufacturing method, a thin polymeric coating forms on the substrate and imparts a microscopically rough texture that can repel water and motor oils.

Ukko Agro

Ukko Agro is building a smart agriculture ecosystem that uses prescriptive disease/pest management models and integrates with external on-farm machinery and equipment via IoT to help farmers optimize crop inputs to achieve higher yields. Ukko Agro ecosystem aims to offer a solution to critical questions about improving yields sustainably and cost-effectively for farmers, meeting sustainability standards for CPGs and in the end benefit consumers.

Androvia LifeSciences LLC

Androvia LifeSciences is a NY-based, privately held company focused on developing new diagnostics that provide a higher level of patient management of male fertility for use by clinicians to counsel couples. The company’s objective is to understand male fertility at its most fundamental level – how it occurs, how it’s measured, and how it can be applied to improve outcomes.

Geegah, LLC

Geegah is developing advanced sensors to offer the most secure and convenient biometric sensors. Based on gigahertz ultrasonics Geegah’s technology employs single-chip biometric solutions with an emphasis on fingerprint sensing.

FloraPulse, Co.

FloraPulse has developed real-time sensors to measure how thirsty a plant is. By knowing how much to irrigate, growers can increase crop yield and product quality, while reducing water use. The company received $224,766 of grant funding from the National Science Foundation in 2018.

Farther Farms, Inc.

Farther Farms is a food processing technology company that has developed a new method to preserve fresh-cut fruits and vegetables for months at room temperature, without preservatives or chemicals.

Versatope Therapeutics, Inc.

Versatope Therapeutics is using exosomes (extracellular vesicles) derived from genetically engineered probiotics as a technology platform for the targeted delivery of large molecules used in vaccines, therapeutics and diagnostics. The company has worked with accelerators/incubators MassCONNECT, MassChallenge, and JLABS.

AffyImmune Therapeutics

AffyImmune is an immuno-oncology company that develops T cell products for cancer therapy. The company was founded based on intellectual property generated from Weill Cornell Medicine that enables imaging of T cells in patients and T cells to specifically target tumors. The company has two products in the pipeline, and are ready to commence clinical trials in 2018

Esper BioSciences, Inc.

Esper Biosciences aims to develop a low-cost, high-speed DNA sequencer, for use in point-of-care medical diagnostics and scientific research.

Airy3D, Inc.

Airy3D is a consumer electronic company developing a suite of passive depth recovery technologies to bring 3D machine vision to any camera. The company raised $10 million of Series A venture funding in 2018. The funding was used to advance its licensing roadmap for the first commercial adoptions of its DepthIQTM 3D sensor platform with top-tier mobile OEMs (original equipment manufacturers). Airy3D has raised $14M in venture capital funding to date.